Qiming Venture Partners is a venture capital firm that offers early-stage healthcare possibilities in highly disruptive platforms.
Qiming Venture Partners USA, founded in 2017, is a healthcare venture capital firm and healthcare investor with deep technical expertise that allows them to identify tomorrow's innovations early and strong operational experience with a hands-on approach that makes us the investor of choice for early-stage biotech companies.Because of their proven, hands-on approach to supporting CEOs and scaling operations, its partners are frequently sought after to serve on company boards. They are respected business and thought leaders.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 6, 2022
Entact Bio
|
Series A | $81M | Biopharma | Yes |